Alone We Can Do So Little,
Together We Can Do So Much

Welcome to Zuvius Lifesciences

Zuvius Lifesciences headquartered in Mumbai, India, is a global healthcare company specializing in chemotherapeutic formulations. Dedicated towards redefining quality of life, our products span the breadth of cancer care. Enriched with a portfolio of leading science-based offerings in oncology care and nutraceuticals, we have delivered values in the lives of people for more than 20 years.

Zuvius is an integrated research-based organization, renowned for its quality and commitment. Built with a vision of making affordable cancer care accessible across the globe, the company has curated a range of 200+ high-quality anti-cancer medicines that reach out to patients. Backed by some of the finest talents of the pharmaceutical industry, Zuvius stands strong in building a legacy of delivering innovative solutions and therapies that would change the perception of cancer.

The word ‘Zuvius’ inspires a ring of positivity, joy and optimism. Zuvius Lifesciences was incepted with the vision of spreading good health across the globe and thereby emerging out as one of the most respected pharmaceutical brands in the industry, specializing in super specialty medicines.

Zuvius Lifesciences is much more than a company, more than simply a manufacturer of super speciality products. We are an eclectic and an ever-expanding mix of people with perspectives and skills to collectively work under the shared responsibility towards our consumers, partners, colleagues and most importantly, towards each other.

CMD’s Message

CMD’s Message

“Taking the world from ‘Know Cancer to No Cancer”
Zuvius exhales a promise of hope that one day the world will be cancer-free. And we believe, we have a big role to play in turning that dream into a reality. We have built this organization brick by brick on one single foundation – to help people fight cancer with access to quality medicines. Perhaps, access to timely diagnosis and quality medicines is all that’s needed to save a million lives each year!!!

Even today, less than 30% of low-income countries have access to cancer treatment services. And only 14% of cancer patients have access to palliative care. We want to change these dynamics; cancer treatment should be accessible and available to all.

In over a decade’s time, we have earned a specialization in chemotherapeutic formulations. Today, we manufacture the widest range of anti-cancer drugs in the country. Keeping up the pace, we are venturing into supportive therapy and nutraceuticals, which too plays a crucial role in bringing solace and comfort to cancer patients.
In this honest quest of eradicating cancer, each person associated with us, the partners, employees, stakeholders, and investors have made an enduring contribution that shall never be forgotten. They have shared our vision of a cancer-free world, trusted us with our potential, guided us along the way, and most importantly stood by us through the highs and lows of this ride.

Nimish Thakkar

(Chairman & Managing Director)

Zuvius Leadership

Zuvius Leadership

Zuvius Lifesciences was founded in 2005, by the Directors – Mr. Nimish Thakkar, Mrs. Alka Chavan and Mr. Shailesh Shetty, with the simple and profound belief of keeping people above profit and quality above quantity. Dr. Ulhas Ganu, a renowned professional with over 30 years of experience in the field of oncology research and medical marketing, joined the team as a technical director. His rich experience brings deep scientific credibility to Zuvius Lifesciences.

Mr. Nimish Thakkar

Chairman & Managing Director

An audacious visionary with excellent entrepreneurial wisdom helps in achieving
international standards with cost-effective methods.

Mrs. Alka Chavan

Director – Sales & Marketing

A seasoned Pharmaceutical Professional with 26 years of Marketing expertise brings out the
best in Management of business units, P&L, Marketing and Sales.

Mr. Shailesh Shetty

Director – Finance, Admin, HR & Operations

An accomplished professional who brings the balance in balance sheets with over 18 years of distinguished experience in Finance, Administration and HR.

Dr. Ulhas Ganu

Technical Director

An ace research scientist, flaunting 27 years of excellency in oncology segment sets the
benchmark of innovation and quality for Zuvius.

Swapnil Kamble:

Director - Marketing

A dynamic leader with 20 years of abundance experience in marketing who brings in the values and culture of young leadership.

Our Mission

Steering towards a world where cancer is just another disease, treatable and curable!Redefining Health, Rediscovering Life

Our Vision

To become a global leader in creating a holistic portfolio of quality cancer care that encompasses every aspect from early diagnosis to treatment to palliative care! 

Our Values

Zuvius respects the dignity of each patient. It’s their quality of life with cancer and post-cancer that matters the most to us. That’s why everything we do imbibes the values of honesty, integrity, quality, commitment, and transparency. 

Timeline

1995
1995

Back to where it all began

With a paltry initial capital, a 19-year-old lad started a medical distribution company in 1995 named Nimish Medical Services that catered to generic medicines covering the central suburbs of Mumbai.

2003
2003

Growing branch by branch

Slowly and steadily, Nimish Medical Services bloomed. It ventured into newer segments – Immunology, Cardiology, Gynecology, Neurology, Nephrology and finally – Oncology

2004
2004

Monopoly is the game


By 2004, the firm earned monopoly in distributing high-end medicines of this niche segment. By this time, the company added two more jewels, Mrs. Alka Chavan and Mr. Shailesh Shetty.

2005
2005

The bigger calling

Life was good and business flourishing. But the team felt the quiver of a bigger calling! They stepped up to set a pharmaceutical company of their own and that marked the birth of ‘Zuvius Life Sciences’.

2006
2006

To new beginnings

Zuvius was built on the foundation of ‘quality care for cancer patients’. We started with a single product and in less than a year, we sprawled across Pan India with a full-fledged team of 28 employees. With great growth came greater responsibilities.

2007
2007

Hitting rock bottom

Zuvius faced a huge crisis that led to crippling loss amounting to crores. A major delay in delivery led to hefty salaries and huge expenses. When stocks arrived, the sales fizzed. The dead stocks lied unsold at various points across the country. With heavy pay outs and zero inflows, Zuvius started to sink.

2008
2008

Falling further apart

We still remember the date, 30th March 2008. Our heart sank as we pulled the shutters down, thinking it was the end we never saw coming. But with a dim gleam of hope, the three of us gathered the grit for one last shot! We called back all the dead stocks from different points and sent out post-dated cheques as refund. Our only hope at that point was to recover the money by selling off the stock.

2010
2010

Resurrecting from the ashes

Our credibility in the industry helped us in picking the pieces. Nimish handled the sales in West India and Alka took over the East. Sailesh stayed back to uphold the pillar once again. It was a harrowing but fulfilling experience. Nimish and Alka allied with distributors from different zones and soon they had the cash flowing in. At the bottom of the abyss, they found a new beginning. The hard work and integrity displayed by the team earned them respect and trust within the industry circle. Zuvius also tucked another feather in the cap with notable research scientist Dr. Ulhas Ganu becoming a part of the core team. In due time, Zuvius became the most respected brand of oncology medication in India.

2015
2015

Growing out and abound

Once, the company strengthened its foothold in the industry there was no looking back. They increased the product range, launched several new molecules for the first time, and continued rigorous research on cancer treatment. By 2015, they had built a portfolio of 70+ anti-cancer drugs. And their dream of building global access to cancer care started to take form. Zuvius registered its products in many countries covering Africa, Latin America, CIS, and South-East Asia. Today, Zuvius is actively invested in research and development of life-saving drugs against cancer. It is making new strides in supportive therapies and nutraceuticals that adds value to the quality of life. And above all, Zuvius is embracing its dream by spanning across borders reaching out to people in need.

2020
2020

Covid Times

The company was expecting a steep growth in coming years, when the world was hit by Covid. Everything came to stand still. Moving around was difficult, from manufacturing to transportation to delivery. But the passion didn’t die. The call for requirement of medicines from hospitals and doctors could be heard loud and clear.

The cancer patients were suffering as many hospitals were turned into covid centers. The patients were in deep stress and were looking for the treatment to be continued. In this challenging time, we ensured that production continues with minimum number of labourers, and we managed to provide supplies. The entire team at Zuvius was dedicated, be it production, sales or back office. They silently fulfilled their duties and served the Cancer patients dedicatedly. The team didn’t give up. We worked together, we cared for each other. Essential members travelled to office, while others worked from home. The sales team were in touch with their clients throughout. Our silent fighters fought the covid times and fought very hard. We demonstrated a great team effort and togetherness. We moved on and sustained.The government indeed help to ensure that medical supplies does not stop.

2022
2022

Onward and Upward, No Turning Back.

This was the time when the market opened and welcomed with open arms. The requirement for anticancer medicines within and outside the nation grew in length and breadth. Simultaneously, with our continuous improvement we launched more products thereby taking our product basket to over 200 products in oncology domain. With the weapon of widest range of anticancer medicines, and consistent quality products, Zuvius leaped to different parts of the world. Capitalizing on such huge opportunity, we connected ourselves to African, Asian, and LatAm countries. With EU GMP certification, we started our journey in regulated European markets as well. We are now exporting to 32 countries.

Timeline

Timeline

  • 1995

    Back to where it all began
    With a paltry initial capital, a 19-year-old lad started a medical distribution company in 1995 named Nimish Medical Services that catered to generic medicines covering the central suburbs of Mumbai.

  • 2003

    Growing branch by branch
    Slowly and steadily, Nimish Medical Services bloomed. It ventured into newer segments – Immunology, Cardiology, Gynecology, Neurology, Nephrology and finally – Oncology.

  • 2004

    Monopoly is the game
    By 2004, the firm earned monopoly in distributing high-end medicines of this niche segment. By this time, the company added two more jewels, Mrs. Alka Chavan and Mr. Shailesh Shetty.

  • 2005

    The bigger calling
    Life was good and business flourishing. But the team felt the quiver of a bigger calling! They stepped up to set a pharmaceutical company of their own and that marked the birth of ‘Zuvius Life Sciences’.

  • 2006

    To new beginnings
    Zuvius was built on the foundation of ‘quality care for cancer patients’. We started with a single product and in less than a year, we sprawled across Pan India with a full-fledged team of 28 employees. With great growth came greater responsibilities.

  • 2007

    Hitting rock bottom
    Zuvius faced a huge crisis that led to crippling loss amounting to crores. A major delay in delivery led to hefty salaries and huge expenses. When stocks arrived, the sales fizzed. The dead stocks lied unsold at various points across the country. With heavy pay outs and zero inflows, Zuvius started to sink.

  • 2008

    Falling further apart
    We still remember the date, 30th March 2008. Our heart sank as we pulled the shutters down, thinking it was the end we never saw coming. But with a dim gleam of hope, the three of us gathered the grit for one last shot! We called back all the dead stocks from different points and sent out post-dated cheques as refund. Our only hope at that point was to recover the money by selling off the stock.

  • 2010

    Resurrecting from the ashes
    Our credibility in the industry helped us in picking the pieces. Nimish handled the sales in West India and Alka took over the East. Sailesh stayed back to uphold the pillar once again. It was a harrowing but fulfilling experience. Nimish and Alka allied with distributors from different zones and soon they had the cash flowing in. At the bottom of the abyss, they found a new beginning. The hard work and integrity displayed by the team earned them respect and trust within the industry circle. Zuvius also tucked another feather in the cap with notable research scientist Dr. Ulhas Ganu becoming a part of the core team. In due time, Zuvius became the most respected brand of oncology medication in India.

  • 2015

    Growing out and abound
    Once, the company strengthened its foothold in the industry there was no looking back. They increased the product range, launched several new molecules for the first time, and continued rigorous research on cancer treatment. By 2015, they had built a portfolio of 70+ anti-cancer drugs. And their dream of building global access to cancer care started to take form. Zuvius registered its products in many countries covering Africa, Latin America, CIS, and South-East Asia. Today, Zuvius is actively invested in research and development of life-saving drugs against cancer. It is making new strides in supportive therapies and nutraceuticals that adds value to the quality of life. And above all, Zuvius is embracing its dream by spanning across borders reaching out to people in need.

  • 2020

    Covid Times
    The company was expecting a steep growth in coming years, when the world was hit by Covid. Everything came to stand still. Moving around was difficult, from manufacturing to transportation to delivery. But the passion didn’t die. The call for requirement of medicines from hospitals and doctors could be heard loud and clear.

    The cancer patients were suffering as many hospitals were turned into covid centers. The patients were in deep stress and were looking for the treatment to be continued. In this challenging time, we ensured that production continues with minimum number of labourers, and we managed to provide supplies. The entire team at Zuvius was dedicated, be it production, sales or back office. They silently fulfilled their duties and served the Cancer patients dedicatedly. The team didn’t give up. We worked together, we cared for each other. Essential members travelled to office, while others worked from home. The sales team were in touch with their clients throughout. Our silent fighters fought the covid times and fought very hard. We demonstrated a great team effort and togetherness. We moved on and sustained.The government indeed help to ensure that medical supplies does not stop.

  • 2022

    This was the time when the market opened and welcomed with open arms. The requirement for anticancer medicines within and outside the nation grew in length and breadth. Simultaneously, with our continuous improvement we launched more products thereby taking our product basket to over 200 products in oncology domain. With the weapon of widest range of anticancer medicines, and consistent quality products, Zuvius leaped to different parts of the world. Capitalizing on such huge opportunity, we connected ourselves to African, Asian, and LatAm countries. With EU GMP certification, we started our journey in regulated European markets as well. We are now exporting to 32 countries.

Our Vision

Lorem

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.